secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001156039-25-000007
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q4 2024 adjusted EPS $3.84, FY 2025 guidance $34.15-$34.85; dividend raised 5% to $1.71
--------------------------------------------------------------------------------

- Q4 operating revenue $45.0B (+6% YoY); FY revenue $175.2B (+3%).
- Q4 GAAP EPS $1.81; adjusted EPS $3.84. FY GAAP EPS $25.68; adjusted EPS $33.04.
- Health Benefits Q4 operating margin 0.6% (down from 2.1% YoY) on higher Medicaid cost trend.
- Carelon Q4 adjusted operating margin 5.3% (up from 4.8% YoY); FY adjusted margin 5.8%.
- FY 2025 adjusted EPS guidance $34.15-$34.85; dividend raised 5% to $1.71, payable 3/25/25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/0001156039-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/elv-20250123.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer